NRF2 Gene and Oxidative Stress Response | Decoding Inflammation

By Alberto Rivera, MD · 2026-05-28 · 6 min read

The Switch Inside Every Cell

When oxidative stress rises, whether from infection, environmental toxins, metabolic dysfunction, or simply the act of breathing, cells do not passively absorb the damage. They activate NRF2. This protein, encoded by the NFE2L2 gene, detaches from its inhibitor KEAP1 and migrates into the nucleus. Once there, it binds the antioxidant response element and switches on more than 200 cytoprotective genes simultaneously.

Glutathione synthesis accelerates. Heme oxygenase-1 rises. Thioredoxin reductase activates. The cell mounts a coordinated molecular defense, not because it was told to, but because NRF2 read the threat and responded.

When the Switch Is Broken

Several SNPs in NFE2L2 reduce baseline NRF2 activity or impair its nuclear translocation under stress. The rs35652124 variant, located in the promoter region, has been associated with reduced transcriptional output. Carriers produce less NRF2 protein before the insult even arrives, meaning the defense system is already at a deficit when oxidative pressure mounts.

A 2025 study in Free Radical Biology and Medicine confirmed that rs35652124 minor allele carriers show significantly blunted NRF2 response to lipopolysaccharide challenge, with downstream reductions in glutathione peroxidase and superoxide dismutase activity. This is not an abstract finding. It maps directly onto clinical phenotypes: accelerated aging, increased neuroinflammation risk, impaired detoxification, and elevated CRP.

The KEAP1 Side of the Equation

NRF2 does not work alone. Its activity is tightly regulated by KEAP1, the protein that sequesters it in the cytoplasm under basal conditions. Variants in the KEAP1 gene can either hyperstabilize this inhibitory complex, keeping NRF2 locked out of the nucleus, or destabilize it, creating constitutive NRF2 activation that paradoxically drives oncogenic signaling.

Pharmacogenomic databases including PharmGKB now catalog KEAP1-NRF2 axis variants as clinically actionable for sulforaphane dosing, N-acetylcysteine response, and resveratrol metabolism. The pathway is not one gene. It is a system, and the system has a genomic signature specific to each person.

What This Means for the Oxygen Free Radical Crisis

The GENEFLAMMATION framework places the Oxygen Free Radical Crisis at the origin of all chronic inflammatory disease. NRF2 is the body's primary counter-response to that crisis. A genome with compromised NRF2 signaling is a genome that cannot suppress the crisis adequately, regardless of diet, lifestyle, or supplement load.

Knowing your NFE2L2 and KEAP1 variants does not just tell you something interesting about your biology. It tells you whether your antioxidant response system is structurally capable of doing its job, and what therapeutic inputs, sulforaphane, liposomal glutathione, NAC, or targeted mitochondrial support, have the highest probability of restoring function at the genomic level.